QLGN - Qualigen Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
--- --- --- --- --- --- --- ---

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.0
Diluted EPS:
-1.0
Basic P/E:
Diluted P/E:
RSI(14) 1m:
0.0
VWAP:
3.2
RVol:

Events

Period Kind Movement Occurred At

Related News